116 research outputs found
Hand-held lactate analyzer as a tool for the real-time measurement of physical fatigue before slaughter and pork quality prediction
The objectives of this study were to assess the relationship between blood lactate variation measured at the plant, and pork quality variation on a large sample size and under commercial preslaughter handling conditions. A total of 600 pigs were randomly chosen on arrival at a commercial slaughter plant and blood samples taken from the ear vein at unloading (UN), after lairage (LA), in the restrainer (RE; before stunning) and at exsanguination (EX) were analysed for lactate content using a Lactate Scout Analyzer (LSA). In order to have a large range of measures, pigs were distributed into two groups; one kept in lairage overnight (G1) and the other for 2 to 3 h (G2) before slaughter. Meat quality was assessed in the Longissimus thoracis (LT), Semimembranosus (SM) and Adductor (AD) muscles by measuring the pH 30 min postmortem (pH1) and at 24 h postmortem (pHu), the colour and the drip loss. Blood lactate levels did not differ between G1 and G2 (P>0.05). A reduced muscle lactate and glucose contents (P=0.02 and P=0.004, respectively) resulting in a lower (P<0.001) glycolytic potential (GP) was observed in the LT muscle of G1 pigs when compared with G2 loins. In the LT muscle of G1 pigs, the lower GP resulted in an increased pHu (r= 120.67; P<0.001), decreased drip loss (r=0.57; P<0.001) and darker colour (r=0.50; P<0.001) compared with G2. In both G1 and G2 pigs, the lower GP was correlated to higher pHu value in the SM and AD muscles (r= 120.73; P<0.001). The greatest correlation was observed in G2 between blood lactate levels at LA and pHu value of the SM and AD muscles (r=0.46 and r=0.44, respectively; P<0.001 for both muscles). The second greatest correlation was found between blood lactate levels at EX and pH1 value in the SM muscle in both groups (r= 120.37 and r= 120.41, respectively; P<0.001 for both groups). Based on the results of this study, it appears that blood lactate levels, as measured by the LSA, reliably reflect the physiological response of pigs to perimortem stress and may help explain the variation in pork quality
Hand-held lactate analyzer as a tool for the real-time measurement of blood lactate during slaughter and pork quality prediction
A total of 600 pigs was randomly chosen on arrival at a commercial slaughter plant and sampled for lactate analysis from the ear vein using a Lactate Scout Analyzer (LSA) at unloading (UN), after lairage (LA), in the restrainer (RE; before stunning), and from the ear vein (EX1) and the bleeding incision (EX2) at exsanguination. Pigs were distributedinto two pen groups, one kept in lairage overnight (G1) and the other kept between 2 and 3 h before slaughter (G2).Meat quality was assessed in the Longissimus dorsi(LD), Semimembranosus (SM) and Adductor(AD) muscles. Data were analyzed using Spearman correlations and the MIXED procedure of SAS. Greater (P=0.009) levels of blood lactate were found in pigs laired longer, which resulted in LD and SM muscles with greater pHu (P=0.03 and P=0.001, respectively), as well as lower L* (P=0.005and P=0.008, respectively)and drip loss (P=0.01 and P=0.02, respectively). The greatest correlation with lactate levels was observed at LA with pHu value of the SM and AD muscles (r=0.40; P<0.001). LSA lactate levels reliably reflect the physiological response of pigs to preslaughter procedures and may help explain the variation in pork quality as measured in the ham muscles
Procedural Complications During Early Versus Late Endovascular Treatment in Acute Stroke: Frequency and Clinical Impact
BACKGROUND AND PURPOSE: Endovascular treatment (EVT) in acute ischemic stroke is effective in the late time window in selected patients. However, the frequency and clinical impact of procedural complications in the early versus late time window has received little attention. METHODS: We retrospectively studied all acute ischemic strokes from 2015 to 2019 receiving EVT in the Acute Stroke Registry and Analysis of Lausanne. We compared the procedural EVT complications in the early (<6 hours) versus late (6-24 hours) window and correlated them with short-term clinical outcome. RESULTS: Among 695 acute ischemic strokes receiving EVT (of which 202 were in the late window), 113 (16.3%) had at least one procedural complication. The frequency of each single, and for overall procedural complications was similar for early versus late EVT (16.2% versus 16.3%, Padj=0.90). Procedural complications lead to a significantly less favorable short-term outcome, reflected by the absence of National Institutes of Health Stroke Scale improvement in late EVT (delta-National Institutes of Health Stroke Scale-24 hours, -2.5 versus 2, Padj=0.01). CONCLUSIONS: In this retrospective analysis of consecutive EVT, the frequency of procedural complications was similar for early and late EVT patients but very short-term outcome seemed less favorable in late EVT patients with complications
Early-versus-Late Endovascular Stroke Treatment: Similar Frequencies of Nonrevascularization and Postprocedural Cerebrovascular Complications in a Large Single-Center Cohort Study.
Endovascular treatment of acute ischemic stroke is now performed more frequently in the late window in radiologically selected patients. However, little is known about whether the frequency and clinical impact of incomplete recanalization and postprocedural cerebrovascular complications differ between early and late windows in the real world.
We retrospectively reviewed all patients with acute ischemic stroke receiving endovascular treatment within 24 hours from 2015 to 2019 and included in the Acute STroke Registry and Analysis of Lausanne. We compared rates of incomplete recanalization and postprocedural cerebrovascular complications (parenchymal hematoma, ischemic mass effect, and 24-hour re-occlusion) in the early (<6 hours) versus late window (6-24 hours, including patients with unknown onset) populations and correlated them with the 3-month clinical outcome.
Among 701 patients with acute ischemic stroke receiving endovascular treatment, 29.2% had late endovascular treatment. Overall, incomplete recanalization occurred in 56 patients (8%), and 126 patients (18%) had at least 1 postprocedural cerebrovascular complication. The frequency of incomplete recanalization was similar in early and late endovascular treatment (7.5% versus 9.3%, adjusted P =.66), as was the occurrence of any postprocedural cerebrovascular complication (16.9% versus 20.5%, adjusted P = .36). When analyzing single postprocedural cerebrovascular complications, rates of parenchymal hematoma and ischemic mass effect were similar (adjusted P = .71, adjusted P = .79, respectively), but 24-hour re-occlusion seemed somewhat more frequent in late endovascular treatment (4% versus 8.3%, unadjusted P = .02, adjusted P = .40). The adjusted 3-month clinical outcome in patients with incomplete recanalization or postprocedural cerebrovascular complications was comparable between early and late groups (adjusted P = .67, adjusted P = .23, respectively).
The frequency of incomplete recanalization and of cerebrovascular complications occurring after endovascular treatment is similar in early and well-selected late patients receiving endovascular treatment. Our results demonstrate the technical success and safety of endovascular treatment in well-selected late patients with acute ischemic stroke
Bioaccumulation of total mercury in the earthworm Eisenia andrei
Earthworms are a major part of the total biomass of soil fauna and play a vital role
in soil maintenance. They process large amounts of plant and soil material and can
accumulate many pollutants that may be present in the soil. Earthworms have been
explored as bioaccumulators for many heavy metal species such as Pb, Cu and Zn but
limited information is available for mercury uptake and bioaccumulation in earth-
worms and very few report on the factors that influence the kinetics of Hg uptake by
earthworms. It is known however that the uptake of Hg is strongly influenced by the
presence of organic matter, hence the influence of ligands are a major factor contribut
-
ing to the kinetics of mercury uptake in biosystems. In this work we have focused on
the uptake of mercury by earthworms (
Eisenia andrei
) in the presence of humic acid
(HA) under varying physical conditions of pH and temperature, done to assess the role
of humic acid in the bioaccumulation of mercury by earthworms from soils. The study
was conducted over a 5-day uptake period and all earthworm samples were analysed
by direct mercury analysis. Mercury distribution profiles as a function of time, bioac-
cumulation factors (BAFs), first order rate constants and body burden constants for
mercury uptake under selected conditions of temperature, pH as well as via the dermal
and gut route were evaluated in one comprehensive approach. The results showed
that the uptake of Hg was influenced by pH, temperature and the presence of HA.
Uptake of Hg
2
+
was improved at low pH and temperature when the earthworms in
soil were in contact with a saturating aqueous phase. The total amount of Hg
2
+
uptake
decreased from 75 to 48
% as a function of pH. For earthworms in dry soil, the uptake
was strongly influenced by the presence of the ligand. Calculated BAF values ranged
from 0.1 to 0.8. Mercury uptake typically followed first order kinetics with rate constants
determined as 0.2 to 1
h
?
1
.Scopus 201
Thrombolysis in stroke patients with elevated inflammatory markers.
OBJECTIVE
To investigate the prognostic value of white blood cell count (WBC) on functional outcome, mortality and bleeding risk in stroke patients treated with intravenous thrombolysis (IVT).
METHODS
In this prospective multicenter study from the TRISP registry, we assessed the association between WBC on admission and 3-month poor outcome (modified Rankin Scale 3-6), mortality and occurrence of symptomatic intracranial hemorrhage (sICH; ECASS-II-criteria) in IVT-treated stroke patients. WBC was used as continuous and categorical variable distinguishing leukocytosis (WBCâ>â10âĂâ109/l) and leukopenia (WBCââ10 mg/l) on outcomes.
RESULTS
Of 10,813 IVT-treated patients, 2527 had leukocytosis, 112 leukopenia and 8174 normal WBC. Increasing WBC (by 1âĂâ109/l) predicted poor outcome (ORadjusted 1.04[1.02-1.06]) but not mortality and sICH. Leukocytosis was independently associated with poor outcome (ORadjusted 1.48[1.29-1.69]) and mortality (ORadjusted 1.60[1.35-1.89]) but not with sICH (ORadjusted 1.17[0.94-1.45]). Leukopenia did not predict any outcome. In a subgroup, combined leukocytosis and elevated CRP had the strongest association with poor outcome (ORadjusted 2.26[1.76-2.91]) and mortality (ORadjusted 2.43[1.86-3.16]) when compared to combined normal WBC and CRP.
CONCLUSION
In IVT-treated patients, leukocytosis independently predicted poor functional outcome and death. Bleeding complications after IVT were not independently associated with leukocytosis
Reperfusion Injury after ischemic Stroke Study (RISKS): single-centre (Florence, Italy), prospective observational protocol study
Introduction Treatments aiming at reperfusion of the
acutely ischaemic brain tissue may result futile or even
detrimental because of the so-called reperfusion injury.
The processes contributing to reperfusion injury involve a
number of factors, ranging from blood\u2013brain barrier (BBB)
disruption to circulating biomarkers. Our aim is to evaluate
the relative effect of imaging and circulating biomarkers in
relation to reperfusion injury.
Methods and analysis Observational hospital-based
study that will include 140 patients who had ischaemic
stroke, treated with systemic thrombolysis, endovascular
treatment or both. BBB disruption will be assessed with
CT perfusion (CTP) before treatment, and levels of a large
panel of biomarkers will be measured before intervention
and after 24 hours. Relevant outcomes will include: (1)
reperfusion injury, defined as radiologically relevant
haemorrhagic transformation at 24 hours and (2) clinical
status 3 months after the index stroke. We will investigate
the separate and combined effect of pretreatment BBB
disruption and circulating biomarkers on reperfusion injury
and clinical status at 3 months. Study protocol is registered
at http://www. clinicaltrials. gov ( ClinicalTrials. gov ID:
NCT03041753).
Ethics and dissemination The study protocol has been
approved by ethics committee of the Azienda Ospedaliero
Universitaria Careggi (Universit\ue0 degli Studi di Firenze).
Informed consent is obtained by each patient at time of
enrolment or deferred when the participant lacks the
capacity to provide consent during the acute phase.
Researchers interested in testing hypotheses with the
data are encouraged to contact the corresponding author.
Results from the study will be disseminated at national
and international conferences and in medical thesis.
Trial registration number NCT03041753
Tree rings record of long-term atmospheric Hg pollution in the Monte Amiata mining district (Central Italy): lessons from the past for a better future.
Does Small Vessel Disease Burden Impact Collateral Circulation in Ischemic Stroke Treated by Mechanical Thrombectomy?
- âŠ